Literature DB >> 31990112

In vivo Glx and Glu measurements from GABA-edited MRS at 3 T.

Tiffany Bell1,2, Elodie S Boudes1,2, Rachelle S Loo1,2, Gareth J Barker3, David J Lythgoe3, Richard A E Edden4,5, R Marc Lebel6, Martin Wilson7, Ashley D Harris1,2.   

Abstract

In vivo quantification of glutamate (Glu) and γ-aminobutyric acid (GABA) using MRS is often achieved using two separate sequences: a short-echo point resolved spectroscopy (PRESS) acquisition for Glu and a Mescher-Garwood PRESS (MEGA-PRESS) acquisition for GABA. The purpose of this study was to examine the agreement of Glu and Glx (the combined signal of glutamate + glutamine) quantified from two different GABA-edited MEGA-PRESS acquisitions (GABA plus macromolecules, GABA+, TE = 68 ms, and macromolecule suppressed, MMSup, TE = 80 ms) with Glu and Glx quantified from a short-echo PRESS (PRESS-35, TE = 35 ms) acquisition. Fifteen healthy male volunteers underwent a single scan session, in which data were acquired using the three acquisitions (GABA+, MMSup and PRESS-35) in both the sensorimotor and anterior cingulate cortices using a voxel size of 3 × 3 × 3 cm3 . Glx and Glu were quantified from the MEGA-PRESS data using both the OFF sub-spectra and the difference (DIFF) spectra. Agreement was assessed using correlation analyses, Bland-Altman plots and intraclass correlation coefficients. Glx quantified from the OFF sub-spectra from both the GABA+ and MMSup acquisitions showed poor agreement with PRESS-35 in both brain regions. In the sensorimotor cortex, Glu quantified from the OFF sub-spectra of GABA+ showed moderate agreement with PRESS-35 data, but this finding was not replicated in the anterior cingulate cortex. Glx and Glu quantified using the DIFF spectra of either MEGA-PRESS sequence were in poor agreement with the PRESS-35 data in both brain regions. In conclusion, Glx and Glu measured from MEGA-PRESS data generally showed poor agreement with Glx and Glu measured using PRESS-35.
© 2020 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Glx; MEGA-; PRESS; PRESSGABA-edited MRS; glutamate

Mesh:

Substances:

Year:  2020        PMID: 31990112      PMCID: PMC7384936          DOI: 10.1002/nbm.4245

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  39 in total

1.  What are we measuring with GABA magnetic resonance spectroscopy?

Authors:  Charlotte J Stagg; Velicia Bachtiar; Heidi Johansen-Berg
Journal:  Commun Integr Biol       Date:  2011-09-01

Review 2.  Handling macromolecule signals in the quantification of the neurochemical profile.

Authors:  Cristina Cudalbu; Vladimir Mlynárik; Rolf Gruetter
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

3.  Macromolecule-suppressed GABA-edited magnetic resonance spectroscopy at 3T.

Authors:  Richard A E Edden; Nicolaas A J Puts; Peter B Barker
Journal:  Magn Reson Med       Date:  2012-07-06       Impact factor: 4.668

4.  Comparative reliability of proton spectroscopy techniques designed to improve detection of J-coupled metabolites.

Authors:  Paul Gerald Mullins; Hongji Chen; Jing Xu; Arvind Caprihan; Charles Gasparovic
Journal:  Magn Reson Med       Date:  2008-10       Impact factor: 4.668

5.  Glutamate quantification by PRESS or MEGA-PRESS: Validation, repeatability, and concordance.

Authors:  Tamar M van Veenendaal; Walter H Backes; Frank C G van Bussel; Richard A E Edden; Nicolaas A J Puts; Albert P Aldenkamp; Jacobus F A Jansen
Journal:  Magn Reson Imaging       Date:  2018-01-03       Impact factor: 2.546

6.  Very short echo time improves the precision of glutamate detection at 3T in 1H magnetic resonance spectroscopy.

Authors:  S Andrea Wijtenburg; Jack Knight-Scott
Journal:  J Magn Reson Imaging       Date:  2011-07-14       Impact factor: 4.813

7.  Spectral-editing measurements of GABA in the human brain with and without macromolecule suppression.

Authors:  Ashley D Harris; Nicolaas A J Puts; Peter B Barker; Richard A E Edden
Journal:  Magn Reson Med       Date:  2014-12-17       Impact factor: 4.668

8.  Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study.

Authors:  Camilo de la Fuente-Sandoval; Pablo León-Ortiz; Mariana Azcárraga; Sylvana Stephano; Rafael Favila; Leonardo Díaz-Galvis; Patricia Alvarado-Alanis; Jesús Ramírez-Bermúdez; Ariel Graff-Guerrero
Journal:  JAMA Psychiatry       Date:  2013-10       Impact factor: 21.596

Review 9.  Proton Magnetic Resonance Spectroscopy: Relevance of Glutamate and GABA to Neuropsychology.

Authors:  Gabriele Ende
Journal:  Neuropsychol Rev       Date:  2015-08-12       Impact factor: 7.444

10.  Macromolecule-suppressed GABA measurements correlate more strongly with behavior than macromolecule-contaminated GABA+ measurements.

Authors:  Mark Mikkelsen; Ashley D Harris; Richard A E Edden; Nicolaas A J Puts
Journal:  Brain Res       Date:  2018-09-19       Impact factor: 3.252

View more
  7 in total

1.  Examination of gamma-aminobutyric acid and glutamate-glutamine levels in association with impulsive behavior in adolescent marijuana users.

Authors:  Punitha Subramaniam; Andrew Prescot; Erin McGlade; Perry Renshaw; Deborah Yurgelun-Todd
Journal:  Drug Alcohol Depend       Date:  2022-01-25       Impact factor: 4.852

2.  Comparison of seven modelling algorithms for γ-aminobutyric acid-edited proton magnetic resonance spectroscopy.

Authors:  Alexander R Craven; Pallab K Bhattacharyya; William T Clarke; Ulrike Dydak; Richard A E Edden; Lars Ersland; Pravat K Mandal; Mark Mikkelsen; James B Murdoch; Jamie Near; Reuben Rideaux; Deepika Shukla; Min Wang; Martin Wilson; Helge J Zöllner; Kenneth Hugdahl; Georg Oeltzschner
Journal:  NMR Biomed       Date:  2022-02-23       Impact factor: 4.478

3.  Macromolecule suppressed GABA levels show no relationship with age in a pediatric sample.

Authors:  Tiffany Bell; Mehak Stokoe; Ashley D Harris
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

4.  Increase in ACC GABA+ levels correlate with decrease in migraine frequency, intensity and disability over time.

Authors:  Aimie L Peek; Andrew M Leaver; Sheryl Foster; Nicolaas A Puts; Georg Oeltzschner; Luke Henderson; Graham Galloway; Karl Ng; Kathryn Refshauge; Trudy Rebbeck
Journal:  J Headache Pain       Date:  2021-12-13       Impact factor: 7.277

5.  Differences in neurometabolites and transcranial magnetic stimulation motor maps in children with attention-deficit/hyperactivity disorder.

Authors:  Cynthia K Kahl; Rose Swansburg; Tasmia Hai; James G Wrightson; Tiffany Bell; Jean-François Lemay; Adam Kirton; Frank P MacMaster
Journal:  J Psychiatry Neurosci       Date:  2022-07-06       Impact factor: 5.699

6.  The association between language-based task-functional magnetic resonance imaging hemodynamics and baseline GABA+ and glutamate-glutamine measured in pre-supplementary motor area: A pilot study in an aging model.

Authors:  Lisa C Krishnamurthy; Isabella Paredes Spir; Natalie O Rocha; Brian J Soher; Edward J Auerbach; Bruce A Crosson; Venkatagiri Krishnamurthy
Journal:  Front Psychiatry       Date:  2022-08-15       Impact factor: 5.435

7.  A role for GABA in the modulation of striatal and hippocampal systems under stress.

Authors:  Nina Dolfen; Menno P Veldman; Mareike A Gann; Andreas von Leupoldt; Nicolaas A J Puts; Richard A E Edden; Mark Mikkelsen; Stephan Swinnen; Lars Schwabe; Geneviève Albouy; Bradley R King
Journal:  Commun Biol       Date:  2021-09-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.